🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
This laboratory study is looking into biomarkers in samples from younger pa...
Status
Completed
Location
Children's Oncology Group
Start Date
2012-08
Trial ID
NCT01642121
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
This is a dual arm (arm 1 and arm 2) multi-centric non-randomized (prospect...
Status
Not Yet Recruiting
Location
UZ Gent
Start Date
2024-09-01
Trial ID
NCT05973825
Treatments Being Tested
RATIONALE: Studying samples of semen from cancer survivors in the laborator...
Status
Terminated
Location
Vanderbilt-Ingram Cancer Center
Start Date
2010-02
Trial ID
NCT01077440
Treatments Being Tested
RATIONALE: Diagnostic procedures that find residual disease may help predic...
Status
Completed
Location
Multiple Locations
Start Date
2012-02
Trial ID
NCT01498302
Treatments Being Tested
This is a pilot clinical trial investigating the addition of haploidentical...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2014-10-10
Trial ID
NCT02130869
RATIONALE: Studying samples of blood from patients treated with sargramosti...
Status
Completed
Location
Multiple Locations
Start Date
2011-06-28
Trial ID
NCT01388569
Treatments Being Tested